Synergistic antitumor effect between gefitinib and fractionated irradiation in anaplastic oligodendrogliomas cannot be predicted by the Egfr signaling activity.

In high-grade gliomas, the identification of patients that could benefit from EGFR inhibitors remains a challenge, hindering the use of these agents. Using xenografts models, we evaluated the antitumor effect of the combined treatment "gefitinib + radiotherapy" and aimed to identify the pr...

Full description

Bibliographic Details
Main Authors: Sophie Pinel, Jihane Mriouah, Marc Vandamme, Alicia Chateau, François Plénat, Eric Guérin, Luc Taillandier, Valérie Bernier-Chastagner, Jean-Louis Merlin, Pascal Chastagner
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3715478?pdf=render